Entera Bio Ltd (ENTX) Stock Price, Quote & News

Company Profile

Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. It also develops EB613, an oral PTH (1-34), that has completed Phase 2 clinical trial for the treatment of post-menopausal women with low bone mineral density and high-risk osteoporosis;...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 2 532 7151

Website: www.enterabio.com

Address:

Kiryat Hadassah Minrav Building, Fifth Floor, Jerusalem, Israel

Jennx6 Mar. 5 at 8:37 PM

$ENTX Seriously...why down? I'll grab a few more, I guess.

0 · Reply

WallStWireAds Mar. 5 at 2:40 PM

$ENTX https://www.benzinga.com/content/51064997/entera-bio-moves-toward-phase-3-with-oral-therapy-that-could-transform-osteoporosis-treatment-nasdaq

0 · Reply

WallStWireAds Mar. 4 at 1:32 PM

$ENTX https://caplynx.io/BYEoxP0

0 · Reply

WallStWireAds Feb. 26 at 1:02 PM

$ENTX https://caplynx.io/ALVNwRp

0 · Reply

WallStWireAds Feb. 25 at 2:07 PM

$ENTX https://alphacatalyst.beehiiv.com/p/an-executive-from-pfizer-just-joined-this-microcap-followed-by-an-insider-buying-spree-nasdaq-entx

0 · Reply

BillionerOfKing Feb. 24 at 9:03 PM

$ENTX Current Stock Price: $1.58 Contracts to trade: $2.5 ENTX Mar 20 2026 Call Entry: $0.10 Exit: $0.14 ROI: 39% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

OfficialStocktwitsUser Feb. 21 at 9:23 PM

$ENTX RSI: 54.03, MACD: -0.0554 Vol: 0.15, MA20: 1.41, MA50: 1.64 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply